Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
| ▸ | KIF11 | P52732 | 10/20 | 0.50 |
| ▸ | PDE2A | O00408 | 3/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | MPL | P40238 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4792748 | 0.84 | KIF11 (0.46) | KIF11PDE2AKDM1ACYP11B1CYP11B2 | |
| SCHEMBL6743200 | 0.84 | PDE2A (0.47) | CES2KIF11PDE2AIDO1MPL | |
| SCHEMBL17187086 | 0.81 | KIF11 (0.47) | CES2KIF11PDE2AKDM1A | |
| SCHEMBL30417923 | 0.80 | CES2 (0.52) | CES2PDE2AIDO1MPL | |
| SCHEMBL2699647 | 0.80 | CES2 (0.52) | CES2PDE2AIDO1MPL | |
| SCHEMBL29827588 | 0.79 | PDE2A (0.50) | CES2PDE2AIDO1MPL | |
| SCHEMBL2147584 | 0.79 | PDE2A (0.50) | CES2PDE2AIDO1MPL | |
| SCHEMBL6061078 | 0.79 | CES2 (0.56) | CES2KIF11PDE2A | |
| SCHEMBL7140205 | 0.78 | PDE2A (0.46) | CES2PDE2AIDO1MPL | |
| SCHEMBL24836121 | 0.78 | PDE2A (0.47) | CES2KIF11PDE2AIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0034731-B1 | TRIFLUOROMETHYLBENZYLIC ESTERS, THEIR INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES | BAYER AG (DE) | 1985-10-30 | — | — | EP | claimed |
| US-20020042541-A1 | Process for producing bis( trifluoromethyl)benzaldehyde | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-04-11 | — | — | US | disclosed |
| EP-0034731-B1 | TRIFLUOROMETHYLBENZYLIC ESTERS, THEIR INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES | BAYER AG (DE) | 1985-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042541-A1 | Process for producing bis( trifluoromethyl)benzaldehyde | BRPF1, PFAS, FLI1 | CES2 1070/4885KIF11 4519/4885PDE2A 3339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.